TABLE 2.
Bacterial strains used in the present study
| Strain | Description | Source or reference |
|---|---|---|
| JE2 | CA-MRSA strain USA300 LAC cured of plasmids | 38 |
| JE2sle1 | sle1::ΦΝΣ transduced from NE1688 (38) into JE2 wild-type | This study |
| JE2clpXI265E | clpXI265E variant from 8325-4 clpXI265E transduced into JE2 wild type | This study |
| JE2clpXI265E,sle1 | sle1::ΦΝΣ transduced from NE1688 (38) into JE2 clpXI265E; ermB | This study |
| JE2mecA | mecA::ΦΝΣ transduced from NE1868 (38) into JE2 wild-type; ermB | This study |
| JE2clpXI265E,mecA | mecA::ΦΝΣ transduced from NE1868 (38) into JE2 clpXI265E; ermB | This study |
| SA564 | Low-passage clinical isolate | 40 |
| SA564sle1 | sle1::ΦΝΣ transduced from NE1688 (38) into SA564 wild type; ermB | This study |
| SA564clpXI265E | SA564 expressing a ClpXI265E variant from the native clpX locus | 21 |
| 8325-4 | Widely used wild-type strain cured of all prophages | 41 |
| 8325-4sle1 | clpXI265E variant from 8325-4 clpXI265E transduced into 8325-4 wild type; ermB | This study |
| 8325-4clpXI265E | 8325-4 expressing a ClpXI265E variant from the native clpX locus | 21 |